Lifeline Pacing Leads #471-07 & #09
by Intermedics, Inc. 510(k)
Active
510(k) K832409
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK832409 | Date12 Aug 1983 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Lifeline Pacing Leads #471-07 & #09 are permanent pacemaker electrodes, designed to deliver electrical impulses to the heart for cardiac pacing. These leads are intended for use within implantable pacemaker systems to regulate heart rhythm in patients requiring chronic pacing support.
These leads are supplied sterile and intended for single-use implantation by qualified medical professionals. They are classified as Class 3 devices under FDA product code DTB and were cleared via a Traditional 510(k) pathway (K832409) in 1983. Compliance with regulatory standards ensures safe use in clinical settings, with no noted MRI safety restrictions in the available data.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these pacing leads reusable or intended for single-use only, and why does that matter for clinical practice?
The Lifeline Pacing Leads #471-07 & #09 are explicitly designed for single-use implantation and are supplied sterile. This ensures patient safety by preventing cross-contamination and maintaining device integrity, as reuse could compromise sterility and lead performance over time. Single-use also aligns with clinical best practices for implantable cardiac devices to minimize infection risks.
What types of patients or clinical scenarios would these leads be used in, based on their design?
These leads are intended for patients requiring chronic cardiac pacing support, such as those with bradycardia (slow heart rate) or conduction system disorders. They are part of implantable pacemaker systems and regulate heart rhythm by delivering electrical impulses directly to the heart muscle. Clinicians would use them in procedures where long-term pacing is necessary, such as for patients with heart block or other chronic arrhythmias.
How should these leads be stored before use, and what precautions should be taken?
Since the leads are sterile, they must be stored in their original packaging until implantation to preserve sterility. The packaging should remain unopened and protected from contamination, moisture, or physical damage. Clinicians should follow manufacturer guidelines for shelf-life and storage conditions (e.g., room temperature, away from direct sunlight) to ensure device functionality and safety before use.
Are there any known restrictions on using these leads in patients who require MRI scans?
The available data does not specify MRI safety restrictions for the Lifeline Pacing Leads #471-07 & #09. However, as with all implantable cardiac devices, MRI use should be carefully evaluated on a case-by-case basis by the treating physician. If MRI is required, the risks versus benefits must be weighed, and the lead’s compatibility with magnetic fields should be confirmed with the manufacturer or clinical guidelines.